L303-2340 Screening compound: 4-(pyrrolidine-1-carbonyl)-1-{4-[5-(thiophen-3-yl)-1,2,4-oxadiazol-3-yl]benzenesulfonyl}piperidine

L303-2340 Screening compound: 4-(pyrrolidine-1-carbonyl)-1-{4-[5-(thiophen-3-yl)-1,2,4-oxadiazol-3-yl]benzenesulfonyl}piperidine
L303-2340 Screening compound: 4-(pyrrolidine-1-carbonyl)-1-{4-[5-(thiophen-3-yl)-1,2,4-oxadiazol-3-yl]benzenesulfonyl}piperidine alternative view

Chemical Structure Depiction of ChemDiv screening compound L303-2340
4-(pyrrolidine-1-carbonyl)-1-{4-[5-(thiophen-3-yl)-1,2,4-oxadiazol-3-yl]benzenesulfonyl}piperidine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L303-2340

Molecular Formula

C22H24N4O4S2 (C22 H24 N4 O4 S2)

Compound Name

4-(pyrrolidine-1-carbonyl)-1-{4-[5-(thiophen-3-yl)-1,2,4-oxadiazol-3-yl]benzenesulfonyl}piperidine

IUPAC name

4-(pyrrolidine-1-carbonyl)-1-{4-[5-(thiophen-3-yl)-124-oxadiazol-3-yl]benzenesulfonyl}piperidine

SMILES

O=C(C(CC1)CCN1S(c(cc1)ccc1-c1noc(-c2cscc2)n1)(=O)=O)N1CCCC1

InChI

InChI=1S/C22H24N4O4S2/c27-22(25-10-1-2-11-25)17-7-12-26(13-8-17)32(28,29)19-5-3-16(4-6-19)20-23-21(30-24-20)18-9-14-31-15-18/h3-6,9,14-15,17H,1-2,7-8,10-13H2

InChI Key

CDZYNEDLTHAUSI-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27243071

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

472.59

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.826

Distribution Coefficient, logD

3.826

Water Solubility, LogSw

-4.01

Polar Surface Area

81.388

Acid Dissociation Constant (pKa)

23.63

Base Dissociation Constant (pKb)

-1.28

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

40.90

L303-2340 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

SmartTM Library (51161 compounds)

Targeted Diversity Library (40567 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L303-2340 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L303-2340?
Check Price and Availability of L303-2340, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L303-2340 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L303-2340
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L303-2340
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L303-2340 available by request